精选一区二区国产_精品国产日韩在线看片_中文在线视频免费观看_久久精品成人免费国产_A级一级黄色视频_在线播放连续内射爽翻天vol_亚洲精品无码av电影在线播放_少妇无码太爽了在线观看免费视频_国产成人精品一区二区秒_av资源免费人体片a级

2023-04-28

Communication Training Session on New Chemical Drugs jointly organized by the Centre for Drug Evaluation, NMPA and Yangtze River Delta Centre for Drug Evaluation and Inspection of NMPA


On 26 April, a new chemical drug communication session was successfully held in Shanghai, jointly hosted by the Centre for Drug Evaluation, NMPA and the Yangtze River Delta Centre for Drug Evaluation and Inspection of NMPA. About 2000 participants, including representatives from drug regulatory authorities, pharmaceutical companies and R&D institutions, attended the meeting.



The training invited Wang Yamin, director of Department of Chemical Pharmacy and Pharmaceuticals of Center for Drug Evaluation of NMPA, and three senior reviewers, Yao Fangyao, Zhao Lei and Shi Fang, to give in-depth lectures on the requirements of pre-application pharmacy communication and exchange for clinical trials of new drugs, pre-phase III clinical trials of new drugs and pre-application pharmacy communication and exchange for marketing applications of new drugs. They cited specific cases and provided on-site answers to the confusion and common problems encountered by enterprises, as well as the pain points and difficulties in innovative drug development. Participants expressed that this training was a convenient service at the doorstep of drug research and development enterprises in the region provided by the Center for Drug Evaluation, NMPA and the Yangtze River Delta Sub-center. They said that the session was full of content and interpretation and is conducive to businesses to do a better job in the R & D and declaration of new drugs and to promote the high-quality development of the pharmaceutical industry in the Yangtze River Delta.


In the next step, the Center and the Yangtze River Delta Sub-center for Drugs will further promote the forward shift of the focus of the drug evaluation work, support the sub-center to provide pre-mature communication and exchange of guidance services for drug research and development in the region, so as to better serve the development strategy of the Yangtze River Delta region.

Translated Excerpts from web article: https://www.cde.org.cn/main/newspic/view/67bc08e14f44b565f54bb3f0def2d469


? Copyright 2023 JiangSu DaLong Pharmaceutical Technology Co., Ltd. 蘇ICP備2023022339號-1 蘇州網(wǎng)站建設(shè)